US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

WallStreetBets

1,605.19

-141.7533-8.11%

Number of Gainers:8

Number of Losers:13

Number of Flat:- -

PE:- -

High:1,644.94

Open:1,643.87

Low:1,564.80

Close:1,746.95

Loading ...

Press Release: XTI Aerospace Appoints AI and Tech Leader Hanna Tomory to Corporate Advisory Board

Wendy's Expected Free Cash Flow, International Expansion Opportunities Create Upside -- Market Talk

Novavax Updates Financial Terms With Takeda for Covid-19 Vaccine Agreement in Japan

MT Newswires Live

CCL Products (India) Declares Final Dividend for Fiscal 2025

MT Newswires Live

BRIEF-Novavax Announces Improved Terms For Collaboration, License Agreement With Takeda For Nuvaxovid In Japan

BRIEF-MARA Announces April Bitcoin Production And Mining Operation Updates \

Wendy's Co Shares up 1.3% Premarket After JP Morgan Raises to Overweight From Neutral

THOMSON REUTERS

Mara Announces Bitcoin Production and Mining Operation Updates for April 2025

THOMSON REUTERS

Mara Holdings Inc - BTC Holdings Increased to 48,237 BTC

THOMSON REUTERS

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement With Takeda for Nuvaxovid® in Japan

THOMSON REUTERS

Novavax Inc - Updated Agreement Includes Upfront Payment and Annual Milestones Related to Regulatory Approvals & Royalties on Net Sales Earned

THOMSON REUTERS

Novavax Inc - Nuvaxovid to Remain Available in Japan

THOMSON REUTERS

Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan

Reddit : Seaport Research Partners Raises to Buy From Neutral

THOMSON REUTERS

Wendy’s price target lowered to $21 from $26 at Loop Capital

BioCryst Pharmaceuticals Shares up 13.7% Premarket After Q1 Results Beat

THOMSON REUTERS

A Little Good News for Rivian Investors

BioCryst Pharmaceuticals Inc: FY 2025 Orladeyo Revenue Guidance Increased to $580 Mln to $600 Mln

THOMSON REUTERS

BioCryst Pharmaceuticals Inc: Expects to Be Profitable for Full Year 2025, a Year Ahead of Schedule

THOMSON REUTERS

BioCryst Pharmaceuticals Q1 EPS USD 0 VS. Ibes Estimate USD -0.07

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4547/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4547","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4547\",,,,,undefined,":{"symbol":"BK4547","market":"US","secType":"PLATE","nameCN":"WallStreetBets","latestPrice":1605.1925,"timestamp":1746561599999,"preClose":1746.9458,"halted":0,"volume":425605349,"delay":0,"changeRate":-0.081143,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-141.753296,"latestTime":"05-06 16:00:00 EDT","open":1643.8693,"high":1644.9402,"low":1564.8038,"amount":26477230945.18033,"amplitude":0.045872,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746624600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.906813,"peRate":-336.53691,"turnoverRate":0.043485,"increases":8,"decrements":13,"flats":0,"marketCap":436156018776,"floatMarketCap":374063936733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4547\",,,,,undefined,":{"symbol":"BK4547","high":1644.9402,"amplitude":0.045872,"preClose":1746.9458,"low":1564.8038,"pbRate":"8.906813","latestPrice":1605.1925,"volume":425605349,"delay":0,"open":1643.8693,"prevYearClose":1374.9788,"prevWeekClose":1758.562,"prevMonthClose":1697.3002,"prevQuarterClose":1326.6976,"fiveDayClose":1678.8159,"twentyDayClose":1210.4252,"sixtyDayClose":1778.4233,"secType":"PLATE","market":"US","turnoverRate":0.043485,"peRate":-336.53691,"marketCap":436156018776,"floatMarketCap":374063936733,"timestamp":1746561599999,"nameCN":"WallStreetBets"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4547\",,,,undefined,":{"bkCode":"BK4547","up":8,"down":13,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4547\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533807584","title":"Press Release: XTI Aerospace Appoints AI and Tech Leader Hanna Tomory to Corporate Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2533807584","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533807584?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:00","pubTimestamp":1746450000,"startTime":"0","endTime":"0","summary":"ENGLEWOOD, Colo., May 5, 2025 /PRNewswire/ -- XTI Aerospace, Inc.  , a pioneer in xVTOL and powered-lift aircraft solutions, today announced the appointment of Hanna Tomory, a senior executive at Palantir Technologies, to its Corporate Advisory Board.Mrs. Tomory is an accomplished engineer and executive, currently leading Palantir Technologies' commercial business in Canada and spearheading strategic initiatives across the U.S. and globally. Palantir is widely regarded as one of the world's most elite software companies, known for deploying cutting-edge AI and ontology-driven data platforms in high-stakes environments. Mrs. Tomory's experience spans large-scale projects in critical infrastructure, manufacturing, telecommunications, and finance as well as other commercial industries and various government sectors across North America, Latin America, and Europe.Mrs. Tomory holds dual master's degrees in industrial engineering and theology from the University of Toronto and has conducted ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTIA","LU1861559042.SGD","BK4547","BK4543","VTOL","BK4613","LU1861558580.USD","BK4588","BK4179","BK4134","BK4023","BK4585"],"gpt_icon":1},{"id":"2533581209","title":"Wendy's Expected Free Cash Flow, International Expansion Opportunities Create Upside -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2533581209","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533581209?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:57","pubTimestamp":1746449820,"startTime":"0","endTime":"0","summary":"0857 ET - Wendy's current stock price provides a value-oriented opportunity with significant upside, say JPMorgan analysts in a research note. The burger chain's equity value is expected to grow as the analysts see a healthy free cash flow profile through FY28. They boost their rating to overweight from neutral but lower the price target to $15 from $17. \"This view is also formed after significantly de-risking the achievement of near term comps expectations and opportunity for medium-long term development--especially in underpenetrated international markets,\" say the analysts. Wendy's rises 1.2% to $12.71 premarket.  ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","BK4547","WEN"],"gpt_icon":0},{"id":"2533171581","title":"Novavax Updates Financial Terms With Takeda for Covid-19 Vaccine Agreement in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2533171581","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533171581?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:50","pubTimestamp":1746449456,"startTime":"0","endTime":"0","summary":"Novavax  said Monday it updated financial terms of an agreement with Takeda  for the development and commercialization of its Covid-19 vaccine, Nuvaxovid, in Japan.The company said the improved financial terms of the amended deal include an upfront payment, compensation tied to the 2024/2025 season, annual milestone payments linked to regulatory approvals, and royalties on seasonal net sales going forward.NVAX shares were 1.1% higher in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVAX","BK4547","BK4568","BNTX","TAK","BK4585","BK4588","BK4139","BK4007","BK4535","BK4548","BK4551"],"gpt_icon":0},{"id":"2533206589","title":"CCL Products (India) Declares Final Dividend for Fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533206589","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533206589?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:38","pubTimestamp":1746448726,"startTime":"0","endTime":"0","summary":"CCL Products (India) (NSE:CCL, 519600) said its board recommended a final dividend of 5 rupees per share for the fiscal year ended March 31, according to a Monday Indian bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CCL","BK4142","BK4517","BK4588","BK4547","BK4585"],"gpt_icon":0},{"id":"2533589301","title":"BRIEF-Novavax Announces Improved Terms For Collaboration, License Agreement With Takeda For Nuvaxovid In Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589301","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589301?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:28","pubTimestamp":1746448113,"startTime":"0","endTime":"0","summary":"BRIEF-Novavax Announces Improved Terms For Collaboration, License Agreement With Takeda For Nuvaxovid In JapanMay 5 (Reuters) - Novavax Inc NVAX.O:NOVAVAX ANNOUNCES SIGNIFICANTLY IMPROVED TERMS FOR CO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUABYWNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","NVAX","BK4588","BK4139","BK4568","BK4585"],"gpt_icon":0},{"id":"2533586739","title":"BRIEF-MARA Announces April Bitcoin Production And Mining Operation Updates \\","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586739","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586739?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:19","pubTimestamp":1746447546,"startTime":"0","endTime":"0","summary":"BRIEF-MARA Announces April Bitcoin Production And Mining Operation Updates \\May 5 (Reuters) - MARA Holdings Inc MARA.O:MARA ANNOUNCES BITCOIN PRODUCTION AND MINING OPERATION UPDATES FOR APRIL 2025MARA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUANPJT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4595","BK4023","BK4516","BK4596","BK4585","BK4600","MARA","BK4547"],"gpt_icon":0},{"id":"2533586909","title":"Wendy's Co Shares up 1.3% Premarket After JP Morgan Raises to Overweight From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586909?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:10","pubTimestamp":1746447059,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nFWN3RD27U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4209","BK4547","WEN"],"gpt_icon":0},{"id":"2533586519","title":"Mara Announces Bitcoin Production and Mining Operation Updates for April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586519","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586519?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:05","pubTimestamp":1746446700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUANPJT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4600","BK4023","BK4585","MARA","BK4547","BK4595","BK4588","BK4596","BK4516"],"gpt_icon":0},{"id":"2533586516","title":"Mara Holdings Inc - BTC Holdings Increased to 48,237 BTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586516?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:05","pubTimestamp":1746446700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUANPJT3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4595","BK4585","MARA","BK4600","BK4596","BK4547","BK4023","BK4516"],"gpt_icon":0},{"id":"2533586869","title":"Novavax Announces Significantly Improved Terms for Collaboration and License Agreement With Takeda for Nuvaxovid® in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586869?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUABYWNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4585","NVAX","BK4588","BK4547","BK4139"],"gpt_icon":0},{"id":"2533586856","title":"Novavax Inc - Updated Agreement Includes Upfront Payment and Annual Milestones Related to Regulatory Approvals &  Royalties on Net Sales Earned","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586856?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446407,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUABYWNX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","BK4547","BK4588","NVAX","BK4585"],"gpt_icon":0},{"id":"2533586842","title":"Novavax Inc - Nuvaxovid to Remain Available in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586842?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUABYWNX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","BK4585","NVAX","BK4547","BK4588"],"gpt_icon":0},{"id":"2533581858","title":"Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2533581858","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533581858?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446400,"startTime":"0","endTime":"0","summary":"Improved financial terms forNovavax and streamlined operations will help both companies better meet the needs of the Japanese market. Forward-Looking Statements|Statements herein relating to the future of Novavax, its operating plans and prospects, the possible achievement of additional milestones under the CLA, and our ability to operate effectively in the Japanese market, are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, antigenic drift or shift in the SARS-CoV-2 spike protein, challenges satisfying, alone or together with partners, various safety, efficacy and product characterization requirements, including those related to process qualification and assay validation, necessary to satisfy applicable regulatory authorities; difficulty obta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/novavax-announces-significantly-improved-terms-120000485.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novavax-announces-significantly-improved-terms-120000485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4535","BK4547","NVAX","BK4588","BK4139","BK4568","BK4548","BNTX","BK4551"],"gpt_icon":0},{"id":"2533473585","title":"Reddit : Seaport Research Partners Raises to Buy From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2533473585","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533473585?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:57","pubTimestamp":1746446243,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nFWN3RD2CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","LU1861215975.USD","LU2290526834.HKD","RDDT","LU1861220033.SGD","LU2360107168.USD","BK4077"],"gpt_icon":0},{"id":"2533858530","title":"Wendy’s price target lowered to $21 from $26 at Loop Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2533858530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533858530?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:38","pubTimestamp":1746445111,"startTime":"0","endTime":"0","summary":"Loop Capital lowered the firm’s price target on Wendy’s (WEN) to $21 from $26 and keeps a Buy rating on the shares. The firm cites the company’s “m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wendys-price-target-lowered-to-21-from-26-at-loop-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wendys-price-target-lowered-to-21-from-26-at-loop-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4547","WEN","BK4209"],"gpt_icon":0},{"id":"2533835885","title":"BioCryst Pharmaceuticals Shares up 13.7% Premarket After Q1 Results Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2533835885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533835885?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:28","pubTimestamp":1746444518,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL4N3RD0KU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2533583871","title":"A Little Good News for Rivian Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2533583871","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533583871?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:15","pubTimestamp":1746443700,"startTime":"0","endTime":"0","summary":"In the latest turn of events, the Trump administration gave some relief on tariffs.Rivian began stockpiling battery components before the tariffs were enacted.The EV maker hopes the upcoming launch of its R2 model will help boost sales.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/05/a-little-good-news-for-rivian-investors/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["ISBC","BK4585","RIVN","BK4211","BK4547","BK4588","BK4596","BK4099","BK4555"],"gpt_icon":1},{"id":"2533930073","title":"BioCryst Pharmaceuticals Inc: FY 2025 Orladeyo Revenue Guidance Increased to $580 Mln to $600 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2533930073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533930073?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXC0D15E:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2533300704","title":"BioCryst Pharmaceuticals Inc: Expects to Be Profitable for Full Year 2025, a Year Ahead of Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2533300704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533300704?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXC0D15E:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCRX","BK4547"],"gpt_icon":0},{"id":"2533300283","title":"BioCryst Pharmaceuticals Q1 EPS USD 0 VS. Ibes Estimate USD -0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2533300283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533300283?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXC0D15E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":35,"pageCount":8,"totalSize":697,"code":"91000000","status":"200"}]}}